Direxion Daily S&P Biotech Bear 3X Shares's (LABD) last reported annual revenue was N/A.
Direxion Daily S&P Biotech Bear 3X Shares's (LABD) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Direxion Daily S&P Biotech Bear 3X Shares's(LABD) is not profitable as of its last reported annual financials.
The net profit margin for Direxion Daily S&P Biotech Bear 3X Shares's(LABD) from its laster reported year is N/A
The return on equity (ROE) for Direxion Daily S&P Biotech Bear 3X Shares's(LABD) from its last reported annual financials is : N/A
The return on assets (ROA) for Direxion Daily S&P Biotech Bear 3X Shares's(LABD) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for Direxion Daily S&P Biotech Bear 3X Shares's(LABD) from its last reported annual financials is : 0.00%
The Debt to Equity ratio for Direxion Daily S&P Biotech Bear 3X Shares's(LABD) from its last reported annual financials is : 0.00%
The dividend yield for Direxion Daily S&P Biotech Bear 3X Shares's(LABD) from its laster reported year is 5.16%
Direxion Daily S&P Biotech Bear 3X Shares's(LABD) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for LABD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
